Elderly Hodgkin Lymphoma Patients Treated With Chemoradiotherapy

• Conditions: Hodgkin Lymphoma, Adult

• Registration Number: NCT03535948
• Lead Sponsor: Central Hospital, Nancy, France

Brief Summary

Outcome of Hodgkin lymphoma patients over than 60 years treated by chemotherapy and/or radiotherapy: retrospective analysis.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-04-24
• Study Start: 2018-05-15
• Study First Submitted QC: 2018-05-23
• Study First Posted: 2018-05-24
• Status Verified: 2019-05
• Last Update Submitted: 2019-06-14
• Last Update Posted: 2019-06-17
• Primary Completion: 2019-11-30
• Study Completion: 2019-12

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

• Patients over than 60 years
• Newly diagnosed Hodgkin lymphoma

Exclusion Criteria

• Data not available

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Progression-free survival	Time between diagnosis and progression or death - up to 100 weeks	From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 100 months

Trial Locations

Locations (2)

CHU Dijon; 🇫🇷 Dijon, France

CHRU Nancy; 🇫🇷 Vandœuvre-lès-Nancy, France